Skip to main content
PepStack
Blutwerte · Marker

Lymphozyten

Lymphocytes · T-cells · B-cells

BlutbildZeitabhängig
Einheit:
x10^9/L
Abbreviation
LYMPH

Lymphocyte count measures the number of lymphocytes in the blood, reflecting the state of the adaptive immune system.

Reference Ranges

Reference
1–3x10^9/L
1
1.5
3
LowNormalHigh
Reference
Optimal
Unit · x10^9/L

Reference ranges can vary slightly based on laboratory standards and patient demographics.

Overview

Übersicht

Lymphocytes, abbreviated as LYMPH, are a type of white blood cell crucial for the immune system's adaptive response. They include T-cells, B-cells, and natural killer cells, each playing distinct roles in identifying and neutralizing pathogens. Researchers have found that lymphocytes are pivotal in immune surveillance and response, with T-cells directly attacking infected cells and B-cells producing antibodies. Clinically, lymphocyte counts are significant in diagnosing and monitoring conditions such as infections, autoimmune diseases, and hematological disorders. Elevated lymphocyte levels can indicate viral infections or chronic inflammatory conditions, while low levels may suggest immunodeficiency or bone marrow suppression. In the context of athletic performance and biohacking, maintaining optimal lymphocyte levels is associated with robust immune function, potentially reducing infection risk and improving recovery times. However, researchers observed that lymphocyte counts can be influenced by factors such as stress, recent infections, and medications, necessitating careful interpretation of results. Time-of-day variation and fasting status may also affect lymphocyte counts, with levels typically peaking in the afternoon. Therefore, standardized testing conditions are recommended for accurate assessment.

Klinische Bedeutung

Elevated lymphocyte levels may indicate viral infections, chronic inflammation, or lymphoproliferative disorders. Reduced levels can suggest immunodeficiency, bone marrow suppression, or acute stress.

Dynamics

Trend Interpretation

Rising Values

Progressively rising lymphocyte counts may suggest a persistent viral infection or chronic inflammatory condition. Retest in 4 weeks if outside the optimal range.

Falling Values

Progressively falling lymphocyte counts could indicate bone marrow suppression or increased stress.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Viral infections
  • Chronic inflammation
  • Lymphoproliferative disorders
  • Autoimmune diseases
  • Stress response
Cause

Low Levels

  • Immunodeficiency
  • Bone marrow suppression
  • Acute stress
  • Chemotherapy
  • Corticosteroid use
Protocol

How to Optimize

Lever

Lifestyle

  • Regular moderate exercise
  • Adequate sleep
  • Stress management
Lever

Nutrition

  • Balanced diet rich in fruits and vegetables
  • Adequate protein intake
Lever

Supplementation

  • Vitamin D
  • Zinc

Note:

Consult a healthcare provider before starting new supplements, especially if underlying health conditions exist.

Testing Guidelines

✓Fasting Not Required
🕐Time-Sensitive

Lymphocyte counts can vary throughout the day, typically peaking in the afternoon.

Testing Frequency

Annually for healthy adults, more frequently if monitoring a specific condition.

Interfering Factors

  • Recent infections
  • Stress
  • Medications such as corticosteroids

Related Peptides & Hormones

Cortisol

May affect

hormone or peptide

Open Research Questions

Current research suggests that the optimal strategies for quantifying tumor-infiltrating lymphocytes (TILs) and understanding the functional profiles of different TIL subpopulations remain debated, with no standardized methods established. Researchers have not yet established definitive reference ranges for TILs across various tumor types, leading to uncertainty in their prognostic value. Additionally, clinical questions regarding the specific roles of TILs in response to immunotherapy and the mechanisms of T cell dysfunction remain unanswered.

48 Research Publications

1,722

Total Citations

22

Human/RCT

3.9

Avg. Influence

2022

Latest

Sort
Filter
#01

Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.

HumanInfluence26.0
809
Researchers investigated the presence of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. They found that PD-1 expression on circulating lymphocytes could identify T cells targeting unique tumor-specific neoantigens, suggesting a noninvasive approach for personalized cancer therapies.
View on PubMed
#02

Tumor infiltrating lymphocytes in early breast cancer.

ReviewInfluence2.0
132
This review addressed the role of tumor-infiltrating lymphocytes (TILs) in breast cancer immunoediting. Researchers found that TILs serve as reliable prognostic biomarkers, particularly in triple-negative and HER2+ subtypes, highlighting their importance in assessing anti-tumor immune activity.
View on PubMed
#03

Role of T cells in cancer immunotherapy: Opportunities and challenges.

ReviewInfluence3.0
106
Researchers discussed the role of T lymphocytes in cancer immunotherapy. They found that T cell-mediated anti-tumor responses are central to novel immunotherapy strategies, including checkpoint blockade and CAR T cell therapy. The study emphasizes the need to understand T cell activation and differentiation for effective cancer treatment.
View on PubMed
#04

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach.

ReviewInfluence3.0
86
Researchers explored the role of tumor-infiltrating lymphocytes (TILs) in immunotherapy for solid tumors. The study emphasizes the need for standardized methods to evaluate TILs and their functional profiles. It highlights the potential of TILs as biomarkers for predicting responses to immune checkpoint inhibitors.
View on PubMed
#05

Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes.

HumanInfluence5.0
80
This study investigated immune changes in breast cancer patients by analyzing cytokine signaling in peripheral blood lymphocytes. Researchers found that dysregulated cytokine signaling in T cells and monocytes may predict relapse risk in breast cancer patients. The results indicate that immune cell alterations are significant biomarkers for assessing the immune status of these patients.
View on PubMed
#06

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer.

Review
67
This study focused on exosomal PD-L1 in cancer, highlighting its role in immune suppression. Researchers found that exosomes can transport PD-L1 to inhibit T cell activity in the tumor microenvironment. The study suggests that exosomal PD-L1 could serve as a potential biomarker for cancer immunotherapy.
View on PubMed
#07

Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology.

ReviewInfluence2.0
65
View on PubMed
#08

Drug-induced lupus.

AnimalInfluence3.0
64
This study examined drug-induced lupus, a condition triggered by long-term medication use. Researchers found that autoimmunity may be initiated by oxidative metabolites of drugs, leading to the activation of autoreactive lymphocytes. The findings suggest that abnormalities in T-cell selection in the thymus are involved in this autoimmune response.
View on PubMed
#09

Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer.

ReviewInfluence1.0
59
Researchers found that tumor-infiltrating lymphocytes (TILs) in early breast cancer are associated with better outcomes and responses to therapy. The study highlights the importance of assessing TILs as prognostic and predictive biomarkers in clinical practice. This review discusses potential applications of TILs in improving treatment strategies.
View on PubMed
#10

Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers.

Human
44
Researchers identified dysfunctional CD16+ CD8 T cells in smokers using single-cell analyses. They found that smoking is associated with an increase in differentiated T cells and a decrease in naïve T cells, indicating immune aging. This study suggests that smoking may lead to immune dysregulation, impacting overall health.
View on PubMed

Publication Trend

Research publications about Lymphozyten over time

8total
1
'17
1
'20
2
'21
1
'22
2
'25
1
'26

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer